Anatomy of the Substantia Nigra and Subthalamic Nucleus on MR Imaging

Neuroimaging Clinics of North America

Volumn 20, Issue 1, 2010, Pages 7-27

  Massey, L A ^a   Yousry, T A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Magnetic resonance imaging; Parkinsonism; Substantia nigra; Subthalamic nucleus

Indexed keywords

IRON; NEUROMELANIN;

ANISOTROPY; BRAIN RADIOGRAPHY; BRAIN REGION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DOPAMINERGIC TRANSMISSION; GRAY MATTER; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; IRON STORAGE; NEUROANATOMY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; DIFFUSION TENSOR IMAGING; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MOVEMENT DISORDERS; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 70549085164     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2009.10.001     Document Type: Review

References (138)

1. Schenck J.F., and Zimmerman E.A. High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed 17 7 (2004) 433-445
2. Francois C., Nguyen-Legros J., and Percheron G. Topographical and cytological localization of iron in rat and monkey brains. Brain Res 215 1-2 (1981) 317-322
3. Dormont D., Ricciardi K.G., Tande D., et al. Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol 25 9 (2004) 1516-1523
4. Drayer B., Burger P., Darwin R., et al. MRI of brain iron. AJR Am J Roentgenol 147 1 (1986) 103-110
5. Bejjani B.P., Dormont D., Pidoux B., et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 92 4 (2000) 615-625
6. Hariz M.I., Krack P., Melvill R., et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 80 1-4 (2003) 96-101
7. Rutledge J.N., Hilal S.K., Silver A.J., et al. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 149 2 (1987) 365-379
8. Aoki S., Okada Y., Nishimura K., et al. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. Radiology 172 2 (1989) 381-385
9. Dexter D.T., Carayon A., Javoy-Agid F., et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 Pt 4 (1991) 1953-1975
10. Dexter D.T., Jenner P., Schapira A.H., et al. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32 Suppl (1992) S94-100
11. Dexter D.T., Wells F.R., Lees A.J., et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52 6 (1989) 1830-1836
12. Jellinger K., Kienzl E., Rumpelmair G., et al. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 59 3 (1992) 1168-1171
13. Castellani R.J., Siedlak S.L., Perry G., et al. Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol 100 2 (2000) 111-114
14. Zecca L., Youdim M.B., Riederer P., et al. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5 11 (2004) 863-873
15. Griffiths P.D., Dobson B.R., Jones G.R., et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 122 Pt 4 (1999) 667-673
16. Kosta P., Argyropoulou M.I., Markoula S., et al. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J Neurol 253 1 (2006) 26-32
17. Coenen V.A., Prescher A., Schmidt T., et al. What is dorso-lateral in the subthalamic Nucleus (STN)?-a topographic and anatomical consideration on the ambiguous description of today's primary target for deep brain stimulation (DBS) surgery. Acta Neurochir (Wien) 150 11 (2008) 1163-1165 [discussion: 1165]
18. Carpenter M., and Sutin J. Human neuroanatomy. 8th edition (1983), Williams & Wilkins, Baltimore (MD)
19. Nieuwenhuys R., Voogd J., and van Huijzen C. The Human central nervous system: a synopsis and atlas. 4th revised edition (2007), Springer, New York
20. Hassler R. [Zur Pathologie der Paralysis agitans und des Postenzephalitischen Parkinsonismus]. J Psychol Neurol 48 (1938) 387-476 [in German]
21. German D.C., Manaye K., Smith W.K., et al. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26 4 (1989) 507-514
22. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 Pt 5 (1991) 2283-2301
23. Gibb W.R., and Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatr 54 5 (1991) 388-396
24. Gibb W.R. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease. Brain Res 581 2 (1992) 283-291
25. Olzewski J., and Baxter D. Cytoarchitecture of the human brain stem. 2nd edition (1982), Karger, Basel
26. Damier P., Hirsch E.C., Agid Y., et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122 Pt 8 (1999) 1421-1436
27. Halliday G.M. Substantia nigra and locus coeruleus. Chapter 14. In: Paxinos G., and Mai J.K. (Eds). The human nervous system. 2nd edition (2004), Elsevier Academic Press 451-461
28. Damier P., Hirsch E.C., Agid Y., et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 Pt 8 (1999) 1437-1448
29. Hardman C.D., Halliday G.M., McRitchie D.A., et al. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata. Exp Neurol 144 1 (1997) 183-192
30. Ozawa T., Paviour D., Quinn N.P., et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127 Pt 12 (2004) 2657-2671
31. Drayer B.P., Olanow W., Burger P., et al. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 159 2 (1986) 493-498
32. Drayer B.P. Imaging of the aging brain. Part II. Pathologic conditions. Radiology 166 3 (1988) 797-806
33. Drayer B.P. Imaging of the aging brain. Part I. Normal findings. Radiology 166 3 (1988) 785-796
34. Solsberg M.D., Fournier D., and Potts D.G. MR imaging of the excised human brainstem: a correlative neuroanatomic study. AJNR Am J Neuroradiol 11 5 (1990) 1003-1013
35. Hirsch W.L., Kemp S.S., Martinez A.J., et al. Anatomy of the brainstem: correlation of in vitro MR images with histologic sections. AJNR Am J Neuroradiol 10 5 (1989) 923-928
36. Flannigan B.D., Bradley Jr. W.G., Mazziotta J.C., et al. Magnetic resonance imaging of the brainstem: normal structure and basic functional anatomy. Radiology 154 2 (1985) 375-383
37. Duguid J.R., De La Paz R., and DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 20 6 (1986) 744-747
38. Braffman B.H., Grossman R.I., Goldberg H.I., et al. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. AJR Am J Roentgenol 152 1 (1989) 159-165
39. Stern M.B., Braffman B.H., Skolnick B.E., et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39 11 (1989) 1524-1526
40. Pujol J., Junque C., Vendrell P., et al. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch Neurol 49 11 (1992) 1119-1122
41. Yagishita A., and Oda M. Progressive supranuclear palsy: MRI and pathological findings. Neuroradiology 38 Suppl 1 (1996) S60-S66
42. Savoiardo M., Strada L., Girotti F., et al. MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 13 4 (1989) 555-560
43. Savoiardo M., Strada L., Girotti F., et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 174 3 Pt 1 (1990) 693-696
44. Savoiardo M., Girotti F., Strada L., et al. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm Suppl 42 (1994) 93-110
45. Antonini A., Leenders K.L., Meier D., et al. T2 relaxation time in patients with Parkinson's disease. Neurology 43 4 (1993) 697-700
46. *-weighted MRI at 3 Tesla. Magn Reson Med 32 3 (1994) 335-341
47. Gorell J.M., Ordidge R.J., Brown G.G., et al. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 45 6 (1995) 1138-1143
48. Graham J.M., Paley M.N., Grunewald R.A., et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123 Pt 12 (2000) 2423-2431
49. Bartzokis G., Cummings J.L., Markham C.H., et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17 2 (1999) 213-222
50. Michaeli S., Oz G., Sorce D.J., et al. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord 22 3 (2007) 334-340
51. Martin W.R., Wieler M., and Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70 16 Pt 2 (2008) 1411-1417
52. Adachi M., Hosoya T., Haku T., et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol 20 8 (1999) 1500-1506
53. Oikawa H., Sasaki M., Tamakawa Y., et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 23 10 (2002) 1747-1756
54. Hutchinson M., and Raff U. Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra. J Neurol Neurosurg Psychiatr 67 6 (1999) 815-818
55. Hutchinson M., and Raff U. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. AJNR Am J Neuroradiol 21 4 (2000) 697-701
56. Hutchinson M., Raff U., and Lebedev S. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 20 3 (2003) 1899-1902
57. Raff U., Hutchinson M., Rojas G.M., et al. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation. Acad Radiol 13 6 (2006) 721-727
58. Hu M.T., White S.J., Herlihy A.H., et al. A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 56 9 (2001) 1195-1200
59. Hu M.T., Scherfler C., Khan N.L., et al. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease. Mov Disord 21 3 (2006) 299-305
60. Minati L., Grisoli M., Carella F., et al. Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. AJNR Am J Neuroradiol 28 2 (2007) 309-313
61. Hutchinson M., and Raff U. Detection of Parkinson's disease by MRI: spin-lattice distribution imaging. Mov Disord 23 14 (2008) 1991-1997
62. Menke R.A., Scholz J., Miller K.L., et al. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 47 2 (2009) 435-441
63. Enochs W.S., Hyslop W.B., Bennett H.F., et al. Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins. Invest Radiol 24 10 (1989) 794-804
64. Sasaki M., Shibata E., Tohyama K., et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 17 11 (2006) 1215-1218
65. Shibata E., Sasaki M., Tohyama K., et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci 5 4 (2006) 197-200
66. Schocke M.F., Seppi K., Esterhammer R., et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58 4 (2002) 575-580
67. Seppi K., Schocke M.F., Esterhammer R., et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60 6 (2003) 922-927
68. Chan L.L., Rumpel H., Yap K., et al. Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatr 78 12 (2007) 1383-1386
69. Vaillancourt D.E., Spraker M.B., Prodoehl J., et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72 16 (2009) 1378-1384
70. Yoshikawa K., Nakata Y., Yamada K., et al. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatr 75 3 (2004) 481-484
71. Eckert T., Sailer M., Kaufmann J., et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21 1 (2004) 229-235
72. Helms G., Draganski B., Frackowiak R., et al. Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. Neuroimage 47 1 (2009) 194-198
73. Purdon Martin J. Hemichorea resulting from a local lesion of the brain. (The syndrome of the body of Luys). Brain 50 (1927) 637-651
74. Rafols J.A., and Fox C.A. The neurons in the primate subthalamic nucleus: a Golgi and electron microscopic study. J Comp Neurol 168 1 (1976) 75-111
75. Hardman C.D., Halliday G.M., McRitchie D.A., et al. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 56 2 (1997) 132-142
76. Yelnik J., and Percheron G. Subthalamic neurons in primates: a quantitative and comparative analysis. Neuroscience 4 11 (1979) 1717-1743
77. Hamani C., Saint-Cyr J.A., Fraser J., et al. The subthalamic nucleus in the context of movement disorders. Brain 127 Pt 1 (2004) 4-20
78. Yelnik J. Functional anatomy of the basal ganglia. Mov Disord 17 Suppl 3 (2002) S15-S21
79. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20 1 (1995) 128-154
80. Shink E., Bevan M.D., Bolam J.P., et al. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73 2 (1996) 335-357
81. Sato F., Parent M., Levesque M., et al. Axonal branching pattern of neurons of the subthalamic nucleus in primates. J Comp Neurol 424 1 (2000) 142-152
82. Joel D., and Weiner I. The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Res Brain Res Rev 23 1-2 (1997) 62-78
83. Temel Y., Kessels A., Tan S., et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 12 5 (2006) 265-272
84. Smith Y., Hazrati L.N., and Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 294 2 (1990) 306-323
85. Limousin P., Pollak P., Benazzouz A., et al. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord 10 5 (1995) 672-674
86. Alvarez L., Macias R., Guridi J., et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord 16 1 (2001) 72-78
87. Miller W.C., and Delong M.R. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of Parkinsonism. In: Carpenter M.B., and Jayaraman A. (Eds). The Basal Ganglia, Vol 2 (1987), Plenum Press, New York 415-427
88. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 4975 (1990) 1436-1438
89. Aziz T.Z., Peggs D., Sambrook M.A., et al. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 6 4 (1991) 288-292
90. Bergman H., Wichmann T., Karmon B., et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72 2 (1994) 507-520
91. Wichmann T., Bergman H., and DeLong M.R. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol 72 2 (1994) 494-506
92. Wichmann T., Bergman H., and DeLong M.R. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 72 2 (1994) 521-530
93. Limousin P., Pollak P., Benazzouz A., et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345 8942 (1995) 91-95
94. Steele J.C., Richardson J.C., and Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10 (1964) 333-359
95. Williams D.R., Holton J.L., Strand C., et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 130 Pt 6 (2007) 1566-1576
96. Gibb W.R., Luthert P.J., and Marsden C.D. Corticobasal degeneration. Brain 112 Pt 5 (1989) 1171-1192
97. Geddes J.F., Hughes A.J., Lees A.J., et al. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 116 Pt 1 (1993) 281-302
98. Schaltenbrand G., and Wahren W. Atlas for Stereotaxy of the Human Brain (1977), Thieme, Stuttgart, New York
99. Zonenshayn M., Rezai A.R., Mogilner A.Y., et al. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 47 2 (2000) 282-292 [discussion: 292-4]
100. Hamani C., Richter E.O., Andrade-Souza Y., et al. Correspondence of microelectrode mapping with magnetic resonance imaging for subthalamic nucleus procedures. Surg Neurol 63 3 (2005) 249-253 [discussion: 253]
101. Chen C.C., Pogosyan A., Zrinzo L.U., et al. Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery. Exp Neurol 198 1 (2006) 214-221
102. Lee C., Young B., and Sanders M.F. The role of the supramammillary commissure in MR localization of the subthalamic nucleus. Stereotact Funct Neurosurg 84 5-6 (2006) 193-204
103. Counelis G.J., Simuni T., Forman M.S., et al. Bilateral subthalamic nucleus deep brain stimulation for advanced PD: correlation of intraoperative MER and postoperative MRI with neuropathological findings. Mov Disord 18 9 (2003) 1062-1065
104. Hariz M., Blomstedt P., and Limousin P. The myth of microelectrode recording in ensuring a precise location of the DBS electrode within the sensorimotor part of the subthalamic nucleus. Mov Disord 19 7 (2004) 863-864
105. McClelland III S., Vonsattel J.P., Garcia R.E., et al. Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clin Neuropathol 26 6 (2007) 267-275
106. den Dunnen W.F., and Staal M.J. Anatomical alterations of the subthalamic nucleus in relation to age: a postmortem study. Mov Disord 20 7 (2005) 893-898
107. Ashkan K., Blomstedt P., Zrinzo L., et al. Variability of the subthalamic nucleus: the case for direct MRI guided targeting. Br J Neurosurg 21 2 (2007) 197-200
108. Patel N.K., Khan S., and Gill S.S. Comparison of atlas- and magnetic-resonance-imaging-based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson's disease. Stereotact Funct Neurosurg 86 3 (2008) 153-161
109. Davies K.G., and Daniluk S. Stereotactic targeting of the subthalamic nucleus: relevance of magnetic resonance-based evaluation of interindividual variation in diencephalic anatomy. Stereotact Funct Neurosurg 86 5 (2008) 330-331
110. Richter E.O., Hoque T., Halliday W., et al. Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg 100 3 (2004) 541-546
111. Menuel C., Garnero L., Bardinet E., et al. Characterization and correction of distortions in stereotactic magnetic resonance imaging for bilateral subthalamic stimulation in Parkinson disease. J Neurosurg 103 2 (2005) 256-266
112. Taoka T., Hirabayashi H., Nakagawa H., et al. "Sukeroku sign" and "dent internal-capsule sign"-identification guide for targeting the subthalamic nucleus for placement of deep brain stimulation electrodes. Neuroradiology 51 1 (2009) 11-16
113. Andrade-Souza Y.M., Schwalb J.M., Hamani C., et al. Comparison of three methods of targeting the subthalamic nucleus for chronic stimulation in Parkinson's disease. Neurosurgery 56 Suppl 2 (2005) 360-368 [discussion: 360-68]
114. Rijkers K., Temel Y., Visser-Vandewalle V., et al. The microanatomical environment of the subthalamic nucleus. Technical note. J Neurosurg 107 1 (2007) 198-201
115. Toda H., Sawamoto N., Hanakawa T., et al. A novel composite targeting method using high-field magnetic resonance imaging for subthalamic nucleus deep brain stimulation. J Neurosurg 111 4 (2009) 737-745
116. Yelnik J., Bardinet E., Dormont D., et al. A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data. Neuroimage 34 2 (2007) 618-638
117. Bardinet E., Bhattacharjee M., Dormont D., et al. A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. J Neurosurg 110 2 (2009) 208-219
118. Slavin K.V., Thulborn K.R., Wess C., et al. Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol 27 1 (2006) 80-84
119. Kitajima M., Korogi Y., Kakeda S., et al. Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0 T. Neuroradiology 50 8 (2008) 675-681
120. Thomas D.L., De Vita E., Roberts S., et al. High-resolution fast spin echo imaging of the human brain at 4.7 T: implementation and sequence characteristics. Magn Reson Med 51 6 (2004) 1254-1264
121. Bourekas E.C., Christoforidis G.A., Abduljalil A.M., et al. High resolution MRI of the deep gray nuclei at 8 Tesla. J Comput Assist Tomogr 23 6 (1999) 867-874
122. Volz S., Hattingen E., Preibisch C., et al. Reduction of susceptibility-induced signal losses in multi-gradient-echo images: application to improved visualization of the subthalamic nucleus. Neuroimage 45 4 (2009) 1135-1143
123. *) contrast using multiple gradient echoes. AJNR Am J Neuroradiol 28 6 (2007) 1093-1094
124. Vertinsky A.T., Coenen V.A., Lang D.J., et al. Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging. AJNR Am J Neuroradiol 30 9 (2009) 1717-1724
125. Manova E.S., Habib C.A., Boikov A.S., et al. Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol 30 3 (2009) 569-574
126. Suhyadhom A., Haq I.U., Foote K.D., et al. A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the fast gray matter acquisition T1 inversion recovery (FGATIR). Neuroimage (2009) 10.1016/j.neuroimage.2009.04.018
127. Price S., Paviour D., Scahill R., et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23 2 (2004) 663-669
128. Salamon N., Sicotte N., Alger J., et al. Analysis of the brain-stem white-matter tracts with diffusion tensor imaging. Neuroradiology 47 (2005) 895-902
129. Wakana S., Jiang H., Nagae-Poetscher L.M., et al. Fiber tract-based atlas of human white matter anatomy. Radiology 230 (2004) 77-87
130. Nagae-Poetscher L.M., Jiang H., Wakana S., et al. High-resolution diffusion tensor imaging of the brain stem at 3 T. AJNR Am J Neuroradiol 25 (2004) 1325-1330
131. Stieltjes B., Kaufmann W.E., van Zijl P.C., et al. Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage 14 (2001) 723-735
132. Nilsson C., Markenroth Bloch K., Brockstedt S., et al. Tracking the neurodegeneration of parkinsonian disorders-a pilot study. Neuroradiology 49 (2007) 111-119
133. Aravamuthan B.R., Stein J.F., and Aziz T.Z. The anatomy and localization of the pedunculopontine nucleus determined using probabilistic diffusion tractography. [corrected]. Br J Neurosurg 22 (2008) S25-S32
134. Muthusamy K.A., Aravamuthan B.R., Kringelbach M.L., et al. Connectivity of the human pedunculopontine nucleus region and diffusion tensor imaging in surgical targeting. J Neurosurg 107 (2007) 814-820
135. Aravamuthan B.R., Muthusamy K.A., Stein J.F., et al. Topography of cortical and subcortical connections of the human pedunculopontine and subthalamic nuclei. Neuroimage 37 (2007) 694-705
136. Johansen-Berg H., Behrens T.E., Sillery E., et al. Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex 15 (2005) 31-39
137. Behrens T.E., Johansen-Berg H., Woolrich M.W., et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 6 (2003) 750-757
138. Zrinzo L., and Zrinzo L.V. Surgical anatomy of the pedunculopontine and peripeduncular nuclei. Br J Neurosurg 22 Suppl 1 (2008) S19-S24